Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Podcast
Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.
Related Resources
On-Demand Educational Webinars
Hospitals need a tool to leverage the use of UDI within their health care organizations to empower the Cost, Quality, Outcomes Movement. This webinar…
Podcasts
As UDI capture and exchange becomes more prevalent across the healthcare ecosystem and as implantable device information is linked to patient outco
On-Demand Educational Webinars
This webinar provides an overview of the reasons for drug shortages, recent advocacy efforts to ameliorate the situation, and action steps…
On-Demand Educational Webinars
Today, health systems are being forced to leverage disparate data from internal and external sources to drive business intelligence solutions. In…
Advisory
EtO Quality Advisory
Overview:
The AHA and AHRMM have released a Quality Advisory on ethylene oxide sterilization of medical de
On-Demand Educational Webinars
The rapid advancement of barcode scanning and RFID technologies coupled with improved interoperability has enabled a new level of data analytics that…